Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Non-Myeloablative Conditioning Regimen (NMCR) for Allogeneic Bone Marrow Transplantation (BMT) in Patients with Severe Aplastic Anemia (SAA).

Joseph Rosenthal, MD, Anna Pawlowska, MD, Ellen Bolotin, MD, PhD, Peter Falk, MD, Cheryl Oliver, RN, Stephen Forman, MD

Blood (2007) 110 (11): 4943.

https://doi.org/10.1182/blood.V110.11.4943.4943

Published: 2007

Journal Articles

Augmenting the Reduced Intensity Conditioning (RIC) Regimen of Fludarabine (FLU) and Melphalan (MEL) by Addition of Total Marrow and Lymph Node Irradiation (TMLI) Using Helical Tomotherapy in Patients (pts) with Advanced Hematological Malignancies.

Joseph Rosenthal, MD, Jeffrey Wong, MD, Anthony Stein, MD, Ellen Bolotin, MD, PhD, Chatchada Karanes, MD, Leslie Popplwell, MD, Auayporn Nademanee, MD, Firoozeh Sahebi, MD, Margaret O’Donnell, MD, Maria Delioukina, MD, George Somlo, MD, Anna Pawlowska, MD, Debbie Hitt, RN, Marianna Shakhnovits, MD, Stephen Forman, MD

Blood (2007) 110 (11): 3021.

https://doi.org/10.1182/blood.V110.11.3021.3021

Published: 2007

Journal Articles

Fludarabine, Cyclophosphamide and ATG Based, Reduced Intensity Conditioning for HLA-Match Sibling Donor Transplant in Severe Aplasic Anemia (SAA) - Case Report.

Anna B. Pawlowska, MD, Ellen Bolotin, MD, Peter Falk, MD, Stephen Forman, MD, Joseph Rosenthal, MD

Blood (2006) 108 (11): 5370.

https://doi.org/10.1182/blood.V108.11.5370.5370

Published: 2006

Journal Articles

Low Risk of Relapse in Pediatric Patients after Double Unit Cord Blood Transplantation.

Joseph Rosenthal, MD, Ellen Bolotin, MD, Anna B. Pawlowska, MD, Peter Falk, MD, Stephen Forman, MD

Blood (2006) 108 (11): 5416.

https://doi.org/10.1182/blood.V108.11.5416.5416

Published: 2006

Journal Articles

High-Dose Therapy (HDT) with Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Poor Prognosis Ewing Family Tumors (EFT).

Ellen Bolotin, MD, PhD, Marianna Shakhnovits, M.P.H., PhD, Laurence Cooper, MD, PhD, Dajun Qian, PhD, Debbie Hitt, R.N., Robert Sweetman, MD, Judith Sato, MD, James Miser, MD, Stephen Forman, MD, Joseph Rosenthal, MD

Blood (2005) 106 (11): 5500.

https://doi.org/10.1182/blood.V106.11.5500.5500

Published: 2005

Journal Articles

Impact of Allogeneic Stem Cell Transplantation (ASCT) on Outcome of Biphenotypic Acute Leukemia (BAL):.

Amrita Y. Krishnan, MD, Karen L. Chang, MD, Henry C. Fung, MD, Margaret O’Donnell, MD, Ravi Bhatia, MD, Ricardo Spielberger, MD, Vinod Pullarkat, MD, Anthony Stein, MD, Neil Kogut, MD, Mark Kirschbaum, MD, Ellen Bolotin, MD, Clarence SarkodeeAdoo, MD, Andrew Dagis, MS, Nigel Cheng, Stephen J. Forman, MD

Blood (2004) 104 (11): 5144.

https://doi.org/10.1182/blood.V104.11.5144.5144

Published: 2004

NARROW

Non-Myeloablative Conditioning Regimen (NMCR) for Allogeneic Bone Marrow Transplantation (BMT) in Patients with Severe Aplastic Anemia (SAA).

Augmenting the Reduced Intensity Conditioning (RIC) Regimen of Fludarabine (FLU) and Melphalan (MEL) by Addition of Total Marrow and Lymph Node Irradiation (TMLI) Using Helical Tomotherapy in Patients (pts) with Advanced Hematological Malignancies.

Fludarabine, Cyclophosphamide and ATG Based, Reduced Intensity Conditioning for HLA-Match Sibling Donor Transplant in Severe Aplasic Anemia (SAA) - Case Report.

Low Risk of Relapse in Pediatric Patients after Double Unit Cord Blood Transplantation.

High-Dose Therapy (HDT) with Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Poor Prognosis Ewing Family Tumors (EFT).

Impact of Allogeneic Stem Cell Transplantation (ASCT) on Outcome of Biphenotypic Acute Leukemia (BAL):.

Email alerts

ASH Publications

American Society of Hematology

Non-Myeloablative Conditioning Regimen (NMCR) for Allogeneic Bone Marrow Transplantation (BMT) in Patients with Severe Aplastic Anemia (SAA).

Augmenting the Reduced Intensity Conditioning (RIC) Regimen of Fludarabine (FLU) and Melphalan (MEL) by Addition of Total Marrow and Lymph Node Irradiation (TMLI) Using Helical Tomotherapy in Patients (pts) with Advanced Hematological Malignancies.

Fludarabine, Cyclophosphamide and ATG Based, Reduced Intensity Conditioning for HLA-Match Sibling Donor Transplant in Severe Aplasic Anemia (SAA) - Case Report.

Low Risk of Relapse in Pediatric Patients after Double Unit Cord Blood Transplantation.

High-Dose Therapy (HDT) with Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Poor Prognosis Ewing Family Tumors (EFT).

Impact of Allogeneic Stem Cell Transplantation (ASCT) on Outcome of Biphenotypic Acute Leukemia (BAL):.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only